Canadian Experience with Penicillamine Therapy for Cystinuria by Dr John C Crawhall (Clinical Biochemistry Division, Royal Victoria Hospital, Montreal, Quebec) The treatment of stone formation in cystinuria is firstly by hydration with a high fluid intake with possible addition of bicarbonate, but there are a certain number of patients who continue to form stones in spite of this regime (Dent et al. 1965 ). D-penicillamine has been shown to be able to initiate thiol-disulphide exchange reactions with cystine to form the more soluble disulphide penicillamine-cysteine disulphide (Crawhall et al. 1963) .
Severe Cystinuria Series
During the eight years that I have been at the Royal Victoria Hospital and McGill University Clinic in Montreal, I have had an opportunity to see a certain number of patients with cystinuria. Some have had mild disease, but 10 have had sufficiently severe disease to need treatment with D-penicillamine. Details of these patients are summarized in Table 1 . Males and females can be equally affected, although in this series there were 6 females and 4 males. The age of onset of symptoms can be in early childhood stretching up through the teens and into the early twenties. Patients who form stones at an older age than this would rarely need penicillamine, but the patient ZM was an exception, being 38 at the time of his first symptoms. The longest duration of treatment has been eight years, and details of some of the longer treatment regimes will be given later. Control of any further stone formation has been a feature of the treatment. In some, but not all cases, elimination of stones in the kidney has taken place. Each patient had had a previous complex history of surgical procedures or, as in the last 3 patients, was found to have large stones in the kidney at presentation.
Complications ofpenicillamine therapy: The most commonly described complication is the delayed hypersensitivity reaction which can occur on about the tenth day of treatment. It is of interest that this has not been a major problem in the patients in this series. The first patient did have such a reaction, but that was while being put on the drug by a urologist in a small community. We desensitized her to the drug, and she has now continued to take the drug longer than any other. Mild intolerance or dislike of the drug has confused the treatment of 2 of these patients, partly because of digestive symptoms. In both cases the patients have now accepted the drug.
In no patient has there been any evidence of severe proteinuria or the nephrotic syndrome. One patient developed a periodic arthritis, which appeared to be related to the administration of the drug, and immunological examination showed a positive LE cell preparation and a positive ANA test. This patient moved to the other side of the country, but I am at present trying to obtain further information from her practitioner in British Columbia.
One patient, ZM, developed Parkinson's disease shortly after the passage of his first cystine calculus at the age of 38. He appeared to have a congenital hypoplastic left kidney and stone formation was controlled by administration of penicillamine, but despite the most active therapeutic measures his Parkinsonism progressed until it eventually led to his death at the age of 58. One other patient developed a transient rash but did not consult his doctor at the time, and it is understood that he stopped the drug temporarily and then restarted it again without any ill effects.
The reason for the relative lack of immunological disease in this series compared with some other published series cannot be submitted to exhaustive proof, but it was a policy that all these patients were admitted to hospital for the commencement of their D-penicillamine therapy which was started at the low dosage and was slowly increased over a period of 10 days. The 2 patients who showed evidence of a rash were actually both outpatients at the time that the drug was commenced. In some patients, the maintenance dosage has been rather less than the usual maximum dosage of 2 g a day, and this possibly may have contributed to the lower incidence of side-effects. L-E ,l1iI Il -,i 1969 Il -,i 1970 Il -,i 1971 Il -,i 1972 Il -,i 1973 Il -,i 1974 Il -,i 1975 Il -,i 1976 The second patient, SG (Fig 2) , had had severe bilateral stone disease. Dissolution of these stones was slow but progressive. However, the patient from time to time became disenchanted with treatment and stopped taking the capsules. These episodes were eventually associated with further stone formation and renal colic, and the Iq patient has ultimately cooperated to the extent of increasing his penicillamine dosage to 3 g a day, 74. 1976 1976 and going on a reduced protein diet with high It S G fluid intake. There is evidence that the one remaining stone in his left kidney is now getting on treatment for smaller in size. over seven years. There were two small breaks in therapy for reasons which will be mentioned below. This patient had had a previous nephrectomy and had continuing recurrence of stones in the remaining kidney during the times of low penicillamine or zero penicillamine dosage. Eventually, one stone became resistant to dissolution, possibly because of the recurrent urinary tract infections which developed. These were coliform infections and were associated with loin pain and fever, and it was thought that the viability of her remaining kidney would be impaired if this continued, so she was operated on again for removal of the remainder of the stone in that kidney. At surgery it was found to be of Details ofpatients still living (Table 1) The patient PL, had her first surgery at the age of 19. She had 2 children successfully in the subsequent two years, but further stone formation following this led to a left nephrectomy. She developed a large stone in the right kidney at the age of 24, at which time she began taking penicillamine. Over the subsequent two years, this stone got a lot smaller, but did not completely disappear. It was therefore decided to stop the penicillamine for a short while to see if she could manage without the treatment. After five months, X-rays showed that the stone got distinctly larger, and with further penicillamine the stone decreased in size and finally seemed to disappear altogether. However, four months after stopping the penicillamine, the stone again reappeared, so the treatment was restarted. Unfortunately, in 1975 she had recurrent episodes of renal infection, and a nephroiithotomy was carried out later that year. Since then she has continued on penicillamine and has remained stone-free.
The second patient, SG, was a male who had his first surgery at the age of 12 years, followed by multiple stone formation and surgery to the right kidney. He began taking penicillamine after a nephrolithotomy in 1970, during which time the surgeon was unable to clear all the stones from the right kidney. His therapeutic regime was somewhat intermittent, but did include a period of experimentation with enteric-coated penicillamine in 1972 because of the epigastric discomfort he was having. This appeared to be successful, but the drug company was unable to maintain a continuous supply. He therefore discontinued taking penicillamine for a period of about a year, but during that time passed a stone on the left side. In 1974, he developed left ureteric obstruction from a large calculus in the left pelvis. Fortunately, the obstruction relieved itself spontaneously on bed rest, and he was again put on a regime of penicillamine and high fluid intake, this time with dietary protein restriction. Subsequently, the remaining stones on the right side have disappeared, the stone on the left has got smaller and his condition continues to improve. The third patient, ML, is also male. He had a history of recurrent renal stone formation starting at the age of nine months, with repeated surgical exploration, firstly on the right and then on the left. When I first met him, he had a stone in the left kidney, the right kidney had been removed as well as the lower pole of the left kidney. Fortunately, on aggressive therapy with penicillamine and a low protein diet the stone disappeared, and he has remained stone-free on a holding dose of penicillamine of 1 g per day for four to five years.
The next patient, DJ, had various surgical procedures between the ages of 13 and 16. In 1969, when she was 17, I started her on penicillamine, 1.5 g per day. She lived over 600 miles away so that continuous coverage was difficult. She stopped taking the drug, but passed two stones in 1972. She came to see me and restarted penicillamine in October of that year, but in December she became pregnant. She did not discontinue the penicillamine till three months later, and gave birth to a normal baby girl in September 1973. Five months after that she passed another stone, and an IVP showed that she had bilateral renal calculi. She began taking penicillamine again and has stayed on that for the two years since then. An IVP shows that there is still a small stone in each kidney, but that her condition is considerably better than it was two years previously.
The next patient, BR, had her first operation at the age of 12 years, and two subsequent episodes of surgery after that. She began taking penicillamine and the stone dissolved, and no more stones were formed. However, in May 1970 she was admitted to hospital because of attacks of joint pain which began five months previously. That was about 1i years after the initiation of penicillamine therapy. There was evidence that withdrawal of the drug improved her condition and that further administration aggravated it. It was felt that she had a drug-induced lupus erythematosus reaction. The drug was stopped, and she moved to the West coast. We are trying to get a follow-up report on her from there.
Another patient, LG, had a left nephrectomy for stone at the age of four years. She had two separate episodes of renal colic in the remaining kidney, and because of persistence of two calculi in the right kidney, she started taking penicillamine, 1.5 g per day. She has not taken the drug consistently, partly because of indigestion, and the dosage has been reduced to 1 g per day. However, she still has the two calculi in the right kidney, and is now debating the advisability of pregnancy while she remains off the drug.
The final three patients in Table 1 are siblings within one family. They live 600 miles away in an isolated community. At the time I first saw them, out of a family of eight children, these three had cystinuria with severe stone disease. There was apparently no consanguinity between the parents. Each of the children appeared to be almost symptom-free despite their staghorn calculi, and over a period of six months to one year I have not so far seen any change in their stone size.
Conclusions
In this series of severely affected patients, the incidence of side-effects of D-penicillamine appears to be somewhat less than in some other reported series. The management of these patients has been made difficult by the large size of the North American continent and the predilection of the patients for living on the two edges. Apart from this, control of stone formation has been achieved, but dissolution of large calculi has been a very slow process and not entirely successful in every case.
